OS9 anticorps (N-Term)

N° du produit ABIN2323690

Détail du produit anti-OS9 anticorps

Antigène: OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))

Épitope: N-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp OS9 est non-conjugé

Application: Western Blotting (WB), Immunoprecipitation (IP)

Réactivité croisée: Humain, Singe, Souris, Rat (Rattus)

Réactivité croisée (Details): Calculated cross reactivity: Hu Mk Mo Rt

Attributs du produit: OS-9 (OS9, Amplified in Osteosarcoma)

Purification: Purified.

Immunogène: Synthetic peptide corresponding to residues near the N-terminal domain of human OS-9. Species Sequence Homology: bovine, hamster

Clone: 13G58

Isotype: IgG

Information d'application

Indications d'application: Optimal working conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Supplied in 10 mM sodium HEPES, pH 7.5, 150 mM NaCl, 100 μg/mL BSA, 50 % glycerol and <0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: -20°C

Détails sur OS9

Antigène: OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))

Autre désignation: OS-9 (OS9 Produits)

Synonymes: anticorps OS-9, anticorps zgc:153838, anticorps 4632413K17Rik, anticorps AU022351, anticorps Os-9, anticorps ERLEC2, anticorps OS9, endoplasmic reticulum lectin, anticorps osteosarcoma amplified 9, endoplasmic reticulum lectin, anticorps amplified in osteosarcoma, anticorps OS9, anticorps os9, anticorps Os9

UniProt: Q13438

Pathways: Maintenance of Protein Location, SARS-CoV-2 Protein Interactome